Key facts
- Surgicure Technologies’s last known valuation is $6.4M (Mar 2025).
- It has raised $6.5M across 1 recorded rounds; the latest was Seed Round ($2.4M) in Sep 2024.
- Notable investors include Techstars, SBXi, VentureWell, Bantam Group, BakerBridge Capital — 19 tracked in total.
- Surgicure Technologies has filed 2 Form Ds with the SEC since 2024, most recently Feb 2025 ($2.4M sold to 64 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 19 names
- ·Watchlist + deal alerts for Surgicure Technologies
Funding rounds
1 roundsAbout Surgicure Technologies
Operator of a medical device company intended for airway management for civilian and military use. The company helps medical professionals reduce adverse events by providing devices that optimize patient breathing, improve deployment speed, and contribute to improved safety and quality of care, enabling doctors to perform surgeries efficiently.
- Sector
- Healthcare
- HQ
- Cambridge, MA, United States
- Founded
- 2018
- Employees
- 8
- Website
- surgicuretech.com/
- Ownership
- Privately Held (backing)
Surgicure Technologies doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Surgicure Technologies shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Surgicure Technologies in its N-PORT filings yet. We sweep new filings monthly.